BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16096767)

  • 21. Opioids and pain.
    Kanjhan R
    Clin Exp Pharmacol Physiol; 1995; 22(6-7):397-403. PubMed ID: 8582088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
    Fischer BD; Carrigan KA; Dykstra LA
    J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NMDA-receptor antagonists and opioid receptor interactions as related to analgesia and tolerance.
    Price DD; Mayer DJ; Mao J; Caruso FS
    J Pain Symptom Manage; 2000 Jan; 19(1 Suppl):S7-11. PubMed ID: 10687332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of DOR prevents remifentanil induced postoperative hyperalgesia through regulating the trafficking and function of spinal NMDA receptors in vivo and in vitro.
    Wang C; Li Y; Wang H; Xie K; Shu R; Zhang L; Hu N; Yu Y; Wang G
    Brain Res Bull; 2015 Jan; 110():30-9. PubMed ID: 25498394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low doses of cyclic AMP-phosphodiesterase inhibitors rapidly evoke opioid receptor-mediated thermal hyperalgesia in naïve mice which is converted to prominent analgesia by cotreatment with ultra-low-dose naltrexone.
    Crain SM; Shen KF
    Brain Res; 2008 Sep; 1231():16-24. PubMed ID: 18656459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perioperative opioid analgesia-when is enough too much? A review of opioid-induced tolerance and hyperalgesia.
    Colvin LA; Bull F; Hales TG
    Lancet; 2019 Apr; 393(10180):1558-1568. PubMed ID: 30983591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphine-6beta-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans.
    van Dorp EL; Kest B; Kowalczyk WJ; Morariu AM; Waxman AR; Arout CA; Dahan A; Sarton EY
    Anesthesiology; 2009 Jun; 110(6):1356-63. PubMed ID: 19461298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid-induced hyperalgesia (OIH).
    Leal Pda C; Clivatti J; Garcia JB; Sakata RK
    Rev Bras Anestesiol; 2010; 60(6):639-47, 355-9. PubMed ID: 21146061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The roles of pain facilitatory systems in opioid tolerance.
    Hsu MM; Wong CS
    Acta Anaesthesiol Sin; 2000 Sep; 38(3):155-66. PubMed ID: 11125691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regionally selective activation of ERK and JNK in morphine paradoxical hyperalgesia: a step toward improving opioid pain therapy.
    Sanna MD; Ghelardini C; Galeotti N
    Neuropharmacology; 2014 Nov; 86():67-77. PubMed ID: 24950452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of mu-opioid and NMDA receptors in the development and maintenance of repeated swim stress-induced thermal hyperalgesia.
    Suarez-Roca H; Silva JA; Arcaya JL; Quintero L; Maixner W; Pinerua-Shuhaibar L
    Behav Brain Res; 2006 Feb; 167(2):205-11. PubMed ID: 16214233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-methyl-D-aspartate receptors involved in morphine-induced hyperalgesia in sensitized mice.
    Ahmadi S; Golbaghi H; Azizbeigi R; Esmailzadeh N
    Eur J Pharmacol; 2014 Aug; 737():85-90. PubMed ID: 24842190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid-induced hyperalgesia: Cellular and molecular mechanisms.
    Roeckel LA; Le Coz GM; Gavériaux-Ruff C; Simonin F
    Neuroscience; 2016 Dec; 338():160-182. PubMed ID: 27346146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Complexity and physiology of the analgesic effects of opioids].
    Simonnet G
    Rev Med Suisse; 2005 Jun; 1(25):1682-5. PubMed ID: 16117034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid hyperalgesia and tolerance versus 5-HT1A receptor-mediated inverse tolerance.
    Xu XJ; Colpaert F; Wiesenfeld-Hallin Z
    Trends Pharmacol Sci; 2003 Dec; 24(12):634-9. PubMed ID: 14654304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid-induced hyperalgesia: pathophysiology and clinical implications.
    Mitra S
    J Opioid Manag; 2008; 4(3):123-30. PubMed ID: 18717507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular interaction in the mouse PAG between NMDA and opioid receptors in morphine-induced acute thermal nociception.
    Ghelardini C; Galeotti N; Vivoli E; Norcini M; Zhu W; Stefano GB; Guarna M; Bianchi E
    J Neurochem; 2008 Apr; 105(1):91-100. PubMed ID: 17996026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex differences in the potency of kappa opioids and mixed-action opioids administered systemically and at the site of inflammation against capsaicin-induced hyperalgesia in rats.
    Lomas LM; Barrett AC; Terner JM; Lysle DT; Picker MJ
    Psychopharmacology (Berl); 2007 Apr; 191(2):273-85. PubMed ID: 17225166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.